Probiotic Mechanisms of Action

Probiotics are live microorganisms that provide health benefits to the host when ingested in adequate amounts. The strains most frequently used as probiotics include lactic acid bacteria and bifidobacteria. Probiotics have demonstrated significant potential as therapeutic options for a variety of diseases, but the mechanisms responsible for these effects have not been fully elucidated yet. Several important mechanisms underlying the antagonistic effects of probiotics on various microorganisms include the following: modification of the gut microbiota, competitive adherence to the mucosa and epithelium, strengthening of the gut epithelial barrier and modulation of the immune system to convey an advantage to the host. Accumulating evidence demonstrates that probiotics communicate with the host by pattern recognition receptors, such as toll-like receptors and nucleotide-binding oligomerization domain-containing protein-like receptors, which modulate key signaling pathways, such as nuclear factor-ĸB and mitogen-activated protein kinase, to enhance or suppress activation and influence downstream pathways. This recognition is crucial for eliciting measured antimicrobial responses with minimal inflammatory tissue damage. A clear understanding of these mechanisms will allow for appropriate probiotic strain selection for specific applications and may uncover novel probiotic functions. The goal of this systematic review was to explore probiotic modes of action focusing on how gut microbes influence the host.

[1]  T. Hirayama,et al.  Production of β‐defensin‐2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein , 2001, FEBS letters.

[2]  S. D. De Keersmaecker,et al.  Adherence factors of Lactobacillus in the human gastrointestinal tract. , 2007, FEMS microbiology letters.

[3]  D. Polk,et al.  Probiotics and immune health , 2011, Current opinion in gastroenterology.

[4]  J. Forstner,et al.  Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide , 1997, Applied and environmental microbiology.

[5]  Yu-Tseung Liu,et al.  Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.

[6]  M. Gelb,et al.  Role of Charge Properties of Bacterial Envelope in Bactericidal Action of Human Group IIA Phospholipase A2against Staphylococcus aureus* , 2002, The Journal of Biological Chemistry.

[7]  D. Sgouras,et al.  In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain Shirota , 2004, Applied and Environmental Microbiology.

[8]  Cheng-Chih Tsai,et al.  Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro. , 2008, Anaerobe.

[9]  Gyu-Sung Cho,et al.  The effect of bacteriocin-producing Lactobacillus plantarum strains on the intracellular pH of sessile and planktonic Listeria monocytogenes single cells. , 2010, International journal of food microbiology.

[10]  Jeffrey I. Gordon,et al.  Angiogenins: a new class of microbicidal proteins involved in innate immunity , 2003, Nature Immunology.

[11]  M. Médici,et al.  Interaction of lactic acid bacteria with the gut immune system , 2002, European Journal of Clinical Nutrition.

[12]  S. Turroni,et al.  DnaK from Bifidobacterium animalis subsp. lactis is a surface-exposed human plasminogen receptor upregulated in response to bile salts. , 2010, Microbiology.

[13]  G. Núñez,et al.  NOD-like receptors: role in innate immunity and inflammatory disease. , 2009, Annual review of pathology.

[14]  J. Buesa,et al.  Novel Probiotic Bifidobacterium longum subsp. infantis CECT 7210 Strain Active against Rotavirus Infections , 2011, Applied and Environmental Microbiology.

[15]  Nod2: a key regulator linking microbiota to intestinal mucosal immunity , 2011, Journal of Molecular Medicine.

[16]  D. Granato,et al.  Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. , 2000, Glycobiology.

[17]  H. Alakomi,et al.  Lactic Acid Permeabilizes Gram-Negative Bacteria by Disrupting the Outer Membrane , 2000, Applied and Environmental Microbiology.

[18]  J. Kvetina,et al.  Effect of probiotic Escherichia coli Nissle components on the Caco-2 cell monolayer integrity , 2010 .

[19]  M. R. Rodríguez Gómez,et al.  Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro. , 2009, International journal of food microbiology.

[20]  J. K. Collins,et al.  Selection of Probiotic Strains for Human Applications , 1998 .

[21]  J. Russell,et al.  The effects of fermentation acids on bacterial growth. , 1998, Advances in microbial physiology.

[22]  H. Sahl,et al.  Lantibiotics: mode of action, biosynthesis and bioengineering. , 2009, Current pharmaceutical biotechnology.

[23]  J. Wells Immunomodulatory mechanisms of lactobacilli , 2011, Microbial cell factories.

[24]  T. Klaenhammer,et al.  Functional Roles of Aggregation-Promoting-Like Factor in Stress Tolerance and Adherence of Lactobacillus acidophilus NCFM , 2010, Applied and Environmental Microbiology.

[25]  A. Margolles,et al.  Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. , 2010, Microbiology.

[26]  S. Salminen,et al.  Resected Human Colonic Tissue: New Model for Characterizing Adhesion of Lactic Acid Bacteria , 2002, Clinical and Vaccine Immunology.

[27]  C. Cherbut,et al.  The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. , 2005, The Journal of nutrition.

[28]  D. Brassart,et al.  Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity , 2000, Gut.

[29]  S. Walsh,et al.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial , 2005, Gut.

[30]  D. Brassart,et al.  Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. , 1997, The American journal of clinical nutrition.

[31]  Y. Lebranchu,et al.  Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. , 2006, The Journal of allergy and clinical immunology.

[32]  S. Vesterlund,et al.  Antimicrobial components from lactic acid bacteria , 1993 .

[33]  C. Dai,et al.  VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. , 2011, International journal of molecular medicine.

[34]  M. Liong Safety of probiotics: translocation and infection. , 2008, Nutrition reviews.

[35]  T. Shimosato,et al.  Immunobiotic Lactobacillus strains augment NLRP3 expression in newborn and adult porcine gut-associated lymphoid tissues. , 2011, Veterinary immunology and immunopathology.

[36]  J. Kvetina,et al.  Caco-2 cell monolayer integrity and effect of probiotic Escherichia coli Nissle 1917 components. , 2010, Neuro endocrinology letters.

[37]  M. Kagnoff,et al.  Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.

[38]  W. MacNaughton,et al.  Probiotic bacteria and intestinal epithelial barrier function. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[39]  J. Schnürer,et al.  Lactobacillus coryniformis subsp.coryniformis Strain Si3 Produces a Broad-Spectrum Proteinaceous Antifungal Compound , 2001, Applied and Environmental Microbiology.

[40]  T. Klaenhammer,et al.  Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture , 1992, Applied and environmental microbiology.

[41]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[42]  M. Selsted,et al.  Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. , 2000, Nature immunology.

[43]  G. Vinderola,et al.  Role of Intestinal Epithelial Cells in Immune Effects Mediated by Gram-Positive Probiotic Bacteria: Involvement of Toll-Like Receptors , 2005, Clinical Diagnostic Laboratory Immunology.

[44]  A. Nusrat,et al.  Inflammatory Bowel Disease and the Apical Junctional Complex , 2006, Annals of the New York Academy of Sciences.

[45]  W. Dobrogosz,et al.  Antagonistic activities of lactic acid bacteria in food and feed fermentations. , 1990, FEMS microbiology reviews.

[46]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[47]  N. Koide,et al.  The Effect of Lactobacillus rhamnosus on Enterohemorrhagic Escherichia coli Infection of Human Intestinal Cells In Vitro , 2003, Microbiology and immunology.

[48]  J. Vanderleyden,et al.  Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens , 2010, Nature Reviews Microbiology.

[49]  James M. Wilson,et al.  Cathelicidins - a family of multifunctional antimicrobial peptides , 2003, Cellular and Molecular Life Sciences CMLS.

[50]  S. Salminen,et al.  Adherence of Probiotic Bacteria to Human Intestinal Mucus in Healthy Infants and during Rotavirus Infection , 2001, Clinical Diagnostic Laboratory Immunology.

[51]  Y. S. Kim,et al.  Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress , 2010, Current gastroenterology reports.

[52]  K. Marchal,et al.  Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. , 2006, FEMS microbiology letters.

[53]  D. Ramón,et al.  Novel Probiotic Bifidobacterium bifidum CECT 7366 Strain Active against the Pathogenic Bacterium Helicobacter pylori , 2010, Applied and Environmental Microbiology.

[54]  J. Grill,et al.  Adhesion of different bifidobacteria strains to human enterocyte‐like Caco‐2 cells and comparison with in vivo study , 1995, Letters in applied microbiology.

[55]  T. Hernandez-Boussard,et al.  Probiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial , 2009, Journal of Gastrointestinal Surgery.

[56]  T. Ganz Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[57]  C. Kuan,et al.  The Improvement of Hypertension by Probiotics: Effects on Cholesterol, Diabetes, Renin, and Phytoestrogens , 2009, International journal of molecular sciences.

[58]  Wenwei Lu,et al.  Characterization of a S-layer protein from Lactobacillus crispatus K313 and the domains responsible for binding to cell wall and adherence to collagen , 2012, Applied Microbiology and Biotechnology.

[59]  C. Grangette,et al.  Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide , 2011, Gut.

[60]  D. Sinderen,et al.  Improvement of the quality and shelf life of wheat bread by fermentation with the antifungal strain Lactobacillus plantarum FST 1.7 , 2007 .

[61]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[62]  S. Salminen,et al.  Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. , 2005, Journal of food protection.

[63]  C. De Simone,et al.  The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[64]  P. Gopal,et al.  In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. , 2001, International journal of food microbiology.

[65]  B. Karska-Wysocki,et al.  Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). , 2010, Microbiological research.

[66]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[67]  Younghoon Kim,et al.  Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. , 2008, Journal of microbiology and biotechnology.

[68]  X. Pelletier,et al.  Hydrogen excretion upon ingestion of dairy products in lactose-intolerant male subjects: importance of the live flora , 2001, European Journal of Clinical Nutrition.

[69]  R. Harvey,et al.  Competitive exclusion treatment reduces the mortality and fecal shedding associated with enterotoxigenic Escherichia coli infection in nursery-raised neonatal pigs. , 2000, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[70]  M. Nagaoka,et al.  Peptidoglycan from lactobacilli inhibits interleukin‐12 production by macrophages induced by Lactobacillus casei through Toll‐like receptor 2‐dependent and independent mechanisms , 2009, Immunology.

[71]  P. Prema,et al.  Production and Characterization of an Antifungal Compound (3-Phenyllactic Acid) Produced by Lactobacillus plantarum Strain , 2010 .

[72]  T. Klaenhammer,et al.  Functional Analysis of Putative Adhesion Factors in Lactobacillus acidophilus NCFM , 2005, Applied and Environmental Microbiology.

[73]  F. Turroni,et al.  Role of Extracellular Transaldolase from Bifidobacterium bifidum in Mucin Adhesion and Aggregation , 2012, Applied and Environmental Microbiology.

[74]  M. Aepfelbacher,et al.  Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells , 2007, Inflammatory bowel diseases.

[75]  A. Haikara,et al.  New types of antimicrobial compounds produced by Lactobacillus plantarum , 1999, Journal of applied microbiology.

[76]  S. Salminen,et al.  Probiotics: an overview of beneficial effects , 2002, Antonie van Leeuwenhoek.

[77]  A. Palva,et al.  Identification by Flagellum Display of an Epithelial Cell- and Fibronectin-Binding Function in the SlpA Surface Protein of Lactobacillus brevis , 2002, Journal of bacteriology.

[78]  L. Hooper,et al.  Epithelial antimicrobial defence of the skin and intestine , 2012, Nature Reviews Immunology.

[79]  R. P. Ross,et al.  Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. , 2012, International journal of food microbiology.

[80]  W. Hammes,et al.  Metabolic and functional properties of lactic acid bacteria in the gastro-intestinal ecosystem: a comparative in vitro study between bacteria of intestinal and fermented food origin. , 2001, Systematic and applied microbiology.

[81]  T. Oelschlaeger Mechanisms of probiotic actions - A review. , 2010, International journal of medical microbiology : IJMM.

[82]  C. Gómez-Llorente,et al.  International Immunonutrition Workshop Session 5 : Early programming of the immune system and the role of nutrition Role of Toll-like receptors in the development of immunotolerance mediated by probiotics , 2010 .

[83]  S. Makino,et al.  Salmonella enteritidis FliC (Flagella Filament Protein) Induces Human β-Defensin-2 mRNA Production by Caco-2 Cells* , 2001, The Journal of Biological Chemistry.

[84]  B. Kimura,et al.  Inhibitory effects of Leuconostoc mesenteroides 1RM3 isolated from narezushi, a fermented fish with rice, on Listeria monocytogenes infection to Caco-2 cells and A/J mice. , 2012, Anaerobe.

[85]  A. Servin,et al.  Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. , 1993, Journal of diarrhoeal diseases research.

[86]  J. Forstner,et al.  Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide , 1999, Journal of applied microbiology.

[87]  T. Toba,et al.  Inhibition of adhesion of food‐borne pathogens to Caco‐2 cells by Lactobacillus strains , 2001, Journal of applied microbiology.

[88]  M. Hollingsworth,et al.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro , 2003, Gut.

[89]  S. Salminen,et al.  The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. , 1999, FEMS immunology and medical microbiology.

[90]  M. G. Johnson,et al.  Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454 , 1999, Journal of applied microbiology.

[91]  A. Margolles,et al.  Lactobacillus plantarum Extracellular Chitin-Binding Protein and Its Role in the Interaction between Chitin, Caco-2 Cells, and Mucin , 2010, Applied and Environmental Microbiology.

[92]  M. Schmidt,et al.  Differential Targeting of the E-Cadherin/β-Catenin Complex by Gram-Positive Probiotic Lactobacilli Improves Epithelial Barrier Function , 2011, Applied and Environmental Microbiology.

[93]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[94]  J. Schnürer,et al.  Lactobacillus plantarum MiLAB 393 Produces the Antifungal Cyclic Dipeptides Cyclo(l-Phe-l-Pro) and Cyclo(l-Phe-trans-4-OH-l-Pro) and 3-Phenyllactic Acid , 2002, Applied and Environmental Microbiology.

[95]  B. Westerlund,et al.  Bacterial proteins binding to the mammalian extracellular matrix , 1993, Molecular microbiology.

[96]  I. Elmadfa,et al.  Regulation of TLR4, p38 MAPkinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. , 2012, Beneficial microbes.

[97]  D. Podolsky,et al.  Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[98]  B. Jung,et al.  Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. , 2012, FEMS microbiology letters.

[99]  S. Turroni,et al.  Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host. , 2009, Microbiology.

[100]  L. Mcfarland Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.

[101]  G. Dalmasso,et al.  Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. , 2005, Research in microbiology.

[102]  L. Morelli,et al.  Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice. , 2005, FEMS immunology and medical microbiology.

[103]  D. Sinderen,et al.  Lactic acid bacteria with potential to eliminate fungal spoilage in foods , 2008, Journal of Applied Microbiology.

[104]  M. Roberfroid,et al.  Functional food science and gastrointestinal physiology and function , 1998, British Journal of Nutrition.

[105]  D. Teitelbaum,et al.  Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model , 2002, Pediatric Surgery International.

[106]  R. Sartor Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[107]  W. D. de Vos,et al.  Functional Characterization of a Mucus-Specific LPXTG Surface Adhesin from Probiotic Lactobacillus rhamnosus GG , 2011, Applied and Environmental Microbiology.

[108]  Jonathan L. Schmid-Burgk,et al.  Inflammasomes: current understanding and open questions , 2011, Cellular and Molecular Life Sciences.

[109]  J. Mueller,et al.  Initial description of the human NLRP3 promoter , 2008, Genes and Immunity.

[110]  J. Alverdy,et al.  Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. , 2006, American journal of physiology. Cell physiology.

[111]  Mitsuyo Matsumoto,et al.  Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. , 2002, FEMS immunology and medical microbiology.

[112]  T. Ganz,et al.  Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[113]  A. Servin,et al.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. , 2004, FEMS microbiology reviews.

[114]  J. Forstner,et al.  Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surfa , 2001, International journal of food microbiology.

[115]  R. D. Rolfe,et al.  POPULATION DYNAMICS OF THE INTESTINAL TRACT , 1991 .

[116]  G. Perdigón,et al.  Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice , 2011, BMC Microbiology.

[117]  Tadao Saito,et al.  Immunobiotic Lactobacillus jensenii Elicits Anti-Inflammatory Activity in Porcine Intestinal Epithelial Cells by Modulating Negative Regulators of the Toll-Like Receptor Signaling Pathway , 2011, Infection and Immunity.

[118]  S. Salminen,et al.  Probiotics in Adhesion of Pathogens: Mechanisms of Action , 2010 .

[119]  J. Tavernier,et al.  TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme , 2008, Cellular and Molecular Life Sciences.

[120]  A. Macpherson,et al.  Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.

[121]  M. Bodinier,et al.  Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions , 2011, Journal of leukocyte biology.

[122]  G. Gibson,et al.  Regulatory effects of bifidobacteria on the growth of other colonic bacteria. , 1994, The Journal of applied bacteriology.

[123]  M. Halpern,et al.  Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[124]  L. De Vuyst,et al.  Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. , 2006, Research in microbiology.

[125]  R. Hughes,et al.  Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. , 2007, The American journal of clinical nutrition.

[126]  Michael J. Miller,et al.  Lactobacillus Adhesion to Mucus , 2011, Nutrients.

[127]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[128]  S. Salminen,et al.  Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance. , 2006, Journal of food protection.

[129]  J. Greene,et al.  Factors involved in adherence of lactobacilli to human Caco-2 cells , 1994, Applied and environmental microbiology.

[130]  J. M. Rhoads,et al.  Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[131]  J. Schnürer,et al.  Antifungal 3-Hydroxy Fatty Acids from Lactobacillus plantarum MiLAB 14 , 2003, Applied and Environmental Microbiology.

[132]  M. Abreu,et al.  TLR Signaling in the Gut in Health and Disease1 , 2005, The Journal of Immunology.

[133]  M. Schmidt,et al.  Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair , 2007, Cellular microbiology.

[134]  M. Kjos,et al.  Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance , 2012, Journal of applied microbiology.

[135]  B. Hirst,et al.  Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin , 2007, Cellular microbiology.

[136]  D. Maskell,et al.  Toll-Like Receptor Expression in C3H/HeN and C3H/HeJ Mice during Salmonella enterica Serovar Typhimurium Infection , 2003, Infection and Immunity.

[137]  M. Karp,et al.  Implication of an Outer Surface Lipoprotein in Adhesion of Bifidobacterium bifidum to Caco-2 Cells , 2008, Applied and Environmental Microbiology.

[138]  L. Nuotio,et al.  Long-term experience with competitive exclusion and salmonellas in Finland. , 1992, International journal of food microbiology.

[139]  William C. Parks,et al.  Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria , 2000, Nature Immunology.

[140]  W. D. de Vos,et al.  Mucosal Adhesion Properties of the Probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED Pilin Subunits , 2010, Applied and Environmental Microbiology.

[141]  K. Heller,et al.  Effect of natural commensal‐origin DNA on toll‐like receptor 9 (TLR9) signaling cascade, chemokine IL‐8 expression, and barrier integritiy of polarized intestinal epithelial cells , 2010, Inflammatory bowel diseases.

[142]  C. Zambonelli,et al.  Antifungal activity of lactobacilli isolated from salami. , 2007, FEMS microbiology letters.

[143]  S. Blum,et al.  Interactions between the microbiota and the intestinal mucosa , 2002, European Journal of Clinical Nutrition.

[144]  D. Polk,et al.  Probiotic Bacterium Prevents Cytokine-induced Apoptosis in Intestinal Epithelial Cells* , 2002, The Journal of Biological Chemistry.

[145]  L. Morelli,et al.  Aggregating Phenotype in Lactobacillus crispatus Determines Intestinal Colonization and TLR2 and TLR4 Modulation in Murine Colonic Mucosa , 2007, Clinical and Vaccine Immunology.

[146]  S. Han,et al.  Lactobacillus acidophilus Expressing Recombinant K99 Adhesive Fimbriae Has an Inhibitory Effect on Adhesion of Enterotoxigenic Escherichia coli , 2005, Microbiology and immunology.

[147]  N. Roy,et al.  Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation , 2010, BMC Microbiology.

[148]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[149]  A. Servin,et al.  Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells. , 1992, Journal of general microbiology.

[150]  G. Molin,et al.  Gut Microbiota and Inflammation , 2011, Nutrients.

[151]  E. Beachey,et al.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. , 1981, The Journal of infectious diseases.

[152]  M. Macouzet,et al.  Production of conjugated linoleic acid by probiotic Lactobacillus acidophilus La‐5 , 2009, Journal of applied microbiology.

[153]  H. Frøkiær,et al.  Toll‐like receptor 2 and nucleotide‐binding oligomerization domain‐2 play divergent roles in the recognition of gut‐derived lactobacilli and bifidobacteria in dendritic cells , 2008, Immunology.

[154]  L. Joosten,et al.  Differential Toll-Like Receptor Recognition and Induction of Cytokine Profile by Bifidobacterium breve and Lactobacillus Strains of Probiotics , 2011, Clinical and Vaccine Immunology.

[155]  M. Kjos,et al.  Antimicrobial Components of Lactic Acid Bacteria , 2011 .

[156]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[157]  Hui-Young Lee,et al.  Antiobesity effect of trans‐10,cis‐12‐conjugated linoleic acid‐producing Lactobacillus plantarum PL62 on diet‐induced obese mice , 2007, Journal of applied microbiology.

[158]  Yan Li,et al.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis , 2011, Inflammatory bowel diseases.

[159]  G. L. Garrote,et al.  Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis. , 2007, International journal of food microbiology.

[160]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[161]  S. Turroni,et al.  Binding of Human Plasminogen to Bifidobacterium , 2007, Journal of bacteriology.

[162]  S. Akira,et al.  Toll-Like Receptors Are Temporally Involved in Host Defense , 2004, The Journal of Immunology.